整体纵向应变与免疫检查点抑制剂相关心肌炎的心脏事件
本研究回顾性比较101例免疫检查点抑制剂(ICI)相关心肌炎患者与92例未发生心肌炎的ICI治疗患者的超声心动图整体纵向应变(GLS)。心肌炎组GLS从ICI前20.3±2.6%降至14.1±2.8%(p<0.001),对照组无变化。中位随访162天,51%发生主要不良心脏事件(MACE),GLS每降低1%,射血分数保留者MACE风险增加4.4倍(HR 4.4,95%CI 2.4-7.8),射血分数降低者增加1.5倍(HR 1.5,95%CI 1.2-1.8)。
要点
- ICI心肌炎患者GLS较基线显著下降,即使射血分数正常。
- GLS降低与MACE风险独立相关,射血分数保留者关联更强。
- GLS可用于ICI心肌炎的检测和风险分层。
核心结论
- ICI心肌炎患者GLS较基线下降,且与MACE风险独立相关,射血分数保留或降低者均如此。
研究设计与样本
- 回顾性研究,比较101例ICI心肌炎患者与92例未发生心肌炎的ICI治疗对照者的超声心动图GLS,部分有ICI前数据。
主要发现
- 心肌炎组GLS从ICI前20.3±2.6%降至14.1±2.8%(p<0.001),对照组无变化(20.6±2.0% vs. 20.5±1.9%,p=0.41)。
- 心肌炎组中60%(61例)射血分数正常,其GLS为15.3±2.0%,射血分数降低者为12.3±2.7%(p<0.001)。
- 中位随访162天,51例(51%)发生MACE。
- 调整EF后,射血分数降低者GLS每降低1%,MACE风险增加1.5倍(HR 1.5,95%CI 1.2-1.8);射血分数保留者增加4.4倍(HR 4.4,95%CI 2.4-7.8)。
临床怎么用
- 对接受ICI治疗的患者,可考虑用超声GLS监测心肌炎并评估MACE风险。
- 即使射血分数正常,GLS降低也应警惕心肌炎及不良事件风险。
局限性
- 回顾性设计,样本量有限(101例病例和92例对照),部分患者缺乏ICI前GLS数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a need for improved methods for detection and risk stratification of myocarditis associated with immune checkpoint inhibitors (ICIs). Global longitudinal strain (GLS) is a sensitive marker of cardiac toxicity among patients receiving standard chemotherapy. There are no data on the use of GLS in ICI myocarditis. OBJECTIVES: This study sought to evaluate the role of GLS and assess its association with cardiac events among patients with ICI myocarditis. METHODS: This study retrospectively compared echocardiographic GLS by speckle tracking at presentation with ICI myocarditis (cases, n = 101) to that from patients receiving an ICI who did not develop myocarditis (control subjects, n = 92). Where available, GLS was also measured pre-ICI in both groups. Major adverse cardiac events (MACE) were defined as a composite of cardiogenic shock, arrest, complete heart block, and cardiac death. RESULTS: Cases and control subjects were similar in age, sex, and cancer type. At presentation with myocarditis, 61 cases (60%) had a normal ejection fraction (EF). Pre-ICI, GLS was similar between cases and control subjects (20.3 ± 2.6% vs. 20.6 ± 2.0%; p = 0.60). There was no change in GLS among control subjects on an ICI without myocarditis (pre-ICI vs. on ICI, 20.6 ± 2.0% vs. 20.5 ± 1.9%; p = 0.41); in contrast, among cases, GLS decreased to 14.1 ± 2.8% (p < 0.001). The GLS at presentation with myocarditis was lower among cases presenting with either a reduced (12.3 ± 2.7%) or preserved EF (15.3 ± 2.0%; p < 0.001). Over a median follow-up of 162 days, 51 (51%) experienced MACE. The risk of MACE was higher with a lower GLS among patients with either a reduced or preserved EF. After adjustment for EF, each percent reduction in GLS was associated with a 1.5-fold increase in MACE among patients with a reduced EF (hazard ratio: 1.5; 95% confidence interval: 1.2 to 1.8) and a 4.4-fold increase with a preserved EF (hazard ratio: 4.4; 95% confidence interval: 2.4 to 7.8). CONCLUSIONS: GLS decreases with ICI myocarditis and, compared with control subjects, was lower among cases presenting with either a preserved or reduced EF. Lower GLS was strongly associated with MACE in ICI myocarditis presenting with either a preserved or reduced EF.
引用
- Awadalla M, Mahmood SS, Groarke JD, et al. Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis. J Am Coll Cardiol. 2020. PMID: 32029128. doi:10.1016/j.jacc.2019.11.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。